Latest news
DDL
Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug delivery in Europe and we are looking forward…
Iconovo has a new granted patent
The Swedish Patent and Registration Office, PRV, has granted Iconovo's first ICOone patent. This is a key milestone showing that Iconovo's inhalers are…
Press releases
Jun 07, 2022, 11:10
News
IR
English
Corporate Information
Other Corporate Information
Jun 03, 2022, 15:57
News
IR
English
Corporate Information
Other Corporate Information
Jun 01, 2022, 07:52
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
May 23, 2022, 10:25
News
IR
Swedish
Corporate Information
Other Corporate Information
May 17, 2022, 13:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 02, 2022, 13:30
News
IR
English
Corporate Information
Other Corporate Information
May 02, 2022, 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
May 02, 2022, 07:30
News
IR
English
Corporate Information
Other Corporate Information
Apr 29, 2022, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 19, 2022, 18:20
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 12, 2022, 08:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 29, 2022, 13:00
News
IR
English
Corporate Information
Other Corporate Information
Mar 25, 2022, 16:45
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Feb 21, 2022, 09:15
News
IR
English
Corporate Information
Other Corporate Information
Feb 18, 2022, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 09, 2022, 10:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 09, 2022, 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Dec 14, 2021, 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Dec 14, 2021, 10:30
News
IR
English
Corporate Information
Other Corporate Information
Nov 19, 2021, 07:18
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
